期刊文献+

银杏达莫联合阿托伐他汀钙治疗急性脑梗死83例疗效观察 被引量:4

下载PDF
导出
摘要 作者于2006年1月至2012年3月来应用银杏达莫联合阿托伐他汀钙治疗急性脑梗死83例,取得较好疗效,现报告如下。1资料与方法1.1一般资料急性脑梗死患者166例,均为我科收治的患者,均符合《各类脑血管疾病诊断要点》的诊断标准[1],经头颅CT或MRI证实急性脑梗死病灶存在或排除脑出血。经取得患者及家属同意后,随机分为治疗组和对照组,治疗组83例,男49例,女34例,年龄48~76岁,平均(61.5±13.8)岁。
出处 《贵州医药》 CAS 2012年第7期638-640,共3页 Guizhou Medical Journal
  • 相关文献

参考文献11

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 2中华医学会神经科学分会.神经外科学分会.临床神经功能缺损程度评分标准(1995)[S].中华神经科杂志,1996,29(6):381.
  • 3章剑今 王敏.银杏叶抗血栓及改善微循环作用的实验研究[J].中国中西医结合杂志,1995,15(5):320-320.
  • 4Verro P, Gorelick P8, Nguyen D. Aspirin plus dipyri- damole versus aspirin for prevention of vascular events after strokeTIA[J]. Stroke, 2008,39 : 1358-1359.
  • 5Hickenbottom SL, Grotta J. Neuroprotective therapy[J]. Semin Neurol, 1998,18 : 485-492.
  • 6Kim HH ,Liao JK. Translational therapeutics of dipyri- damole[J]. Arterioscler Thromb Vasc Biol, 2008,28: s39-s42.
  • 7Hess DC, Demchuk AM, Brass LM, et al. HMG-COA reductase inhibitors (statins)a promising approach to stroke prevention [J]. Neurology, 2000, 54 (4) : 790- 796.
  • 8刘志军,范生尧.他汀类药物预防缺血性卒中及其机制的研究进展[J].国外医学(脑血管疾病分册),2003,11(4):260-262. 被引量:54
  • 9Vaughan CJ,Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke [J ]. Stroke, 1999,30(9): 1969-1973.
  • 10赵水平,吴军,谭利明,胡治平,肖志杰,聂赛,周宏年,蒋波.他汀类药物对急性脑梗死的抗炎作用[J].中华医学杂志,2005,85(40):2841-2845. 被引量:48

二级参考文献50

  • 1周冀英,董为伟.脑梗死患者循环白细胞对内皮细胞金属蛋白酶9表达的影响[J].中华医学杂志,2004,84(12):979-981. 被引量:15
  • 2Farnier M, Davignon J. Current and future treatment of hyperlipidemia: the role of statins. Am J Cardiol, 1998, 82: 3J - 10J.
  • 3Scandinavian Simvastatin Survival Study Gtoup.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival study(4S). Lancet, 1994, 344:1383 - 1389.
  • 4Sacks FM, Pfeffer MA, Moye LA, et al. for the cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med, 1996, 335:1001 - 1009.
  • 5The Long-Term Intervention with Pravastatin ia Ischaemic Disease(LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998, 339:1349 - 1357.
  • 6Plehn JF, Davis BR Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events(CARE)study. the CARE Investigators. Circulation,1999, 99:216 -223.
  • 7Pedersen TR, Kjekshus J, Pyorala K, et al. Eeffect of simvastatin on ischemia signs and symptoms ia the Scandinavian Simvastatin Survival Study(4S). Am J Cardiol, 1998, 81:333 -335.
  • 8Shepherd J, Cobbe SM, Ford I, et al. for the West Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med,1995, 333:1301 - 1307.
  • 9Crouse JR, Byington RP, Hoen HM, et al. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med, 1997, 157:1305 -1310.
  • 10Downs JR, Clearfield M, Weis S, et al. for the AFCAPS/Tex CAPS Research Group. Primary prevention of acute coronary events with lovastatin ka men and women with average cholesterol levels. JAMA,1998, 279:1515 - 1622.

共引文献33130

同被引文献38

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部